ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
루푸스 치료제 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.2%로 40억 7,000만 달러로 성장할 것입니다. 예측 기간의 성장은 의약품 승인 및 출시 증가, 신흥 시장, 질병 인식 및 진단 개선, 인식 제고 활동 증가, 면역억제 제품 등에 기인합니다. 예측 기간의 주요 동향으로는 키메라 항원 수용체 T세포(CAR-T) 치료제, 루푸스 저분자 치료제, 루푸스 CAR-NK 치료제, 전신성 홍반성 루푸스(SLE)에서 인간 형질세포 유사 수지상 세포 활성의 복합 억제, 소변 단백질체학 등이 있습니다.
향후 5년간 8.2%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 스위스나 독일에서 조달하는 루푸스 생물학적 제제의 비용을 상승시킴으로써 미국을 괴롭히고, 환자의 첨단 치료 접근성을 제한하며, 류마티스학과 지출을 증가시킬 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
루푸스 치료제 시장의 성장은 연구개발 활동의 활성화로 인해 촉진될 것으로 예상됩니다. 이러한 활동에는 다양한 분야의 지식, 기술, 제품 개발을 향상시키기 위한 체계적인 연구와 실험이 포함됩니다. R&D 활동은 혁신, 기술 발전, 새로운 도전에 대한 대응, 의료 성과 개선, 과학 기술 혁신을 통한 경제 성장 촉진 등의 필요성에 의해 추진되고 있습니다. 연구 개발 노력은 새로운 치료법을 발견하고, 기존 치료법을 강화하며, 질병의 근본적인 메커니즘을 더 잘 이해함으로써 루푸스 치료제의 발전에 기여할 수 있습니다. 예를 들어, 미국 의회 조사국이 2023년 3월에 발표한 보고서에 따르면, 국립보건원이 2023년에 받은 연구개발비는 491억 8,300만 달러로 2021년에 배정된 429억 4,100만 달러보다 증가하였다고 합니다. 이러한 자금 지원은 루푸스 치료제와 관련된 노력을 포함한 의학 연구 추진에 대한 약속을 강조하고, 시장 성장을 촉진하는 데 도움이 될 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 루푸스 치료제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 루푸스 치료제 시장 : 성장률 분석
세계의 루푸스 치료제 시장 실적 : 규모와 성장, 2019-2024
세계의 루푸스 치료제 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 루푸스 치료제 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 루푸스 치료제 시장 : 질환 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
전신홍반루푸스(SLE)
피부홍반루푸스
약제 유발성 홍반루푸스
신생아 루푸스
세계의 루푸스 치료제 시장 : 치료 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
비스테로이드성 항염증제(NSAIDs)
생물학적 제제
항말라리아제
코르티코스테로이드
기타 치료 종류
세계의 루푸스 치료제 시장 : 투여 경로별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경구
피하
정맥내
기타 투여 경로
세계의 루푸스 치료제 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원과 진료소
진단 검사실
기타 최종사용자
세계의 루푸스 치료제 시장 : 하위 세분화 전신홍반루푸스(SLE), 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
경도 SLE
중등도 SLE
중증 SLE
세계의 루푸스 치료제 시장 : 하위 세분화 피부홍반루푸스(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
급성 피부 루푸스
아급성 피부 루푸스
만성 피부 루푸스(원판상 루푸스를 포함)
세계의 루푸스 치료제 시장 : 하위 세분화 약제 유발성 홍반루푸스(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
약제 유발성 루푸스를 유발하는 일이 알려져 있는 약제
하이드랄라진
프로 카인 아미드
이소니아지드
세계의 루푸스 치료제 시장 : 하위 세분화 신생아 루푸스(유형별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
심장 관련 신생아 루푸스
피부 관련 신생아 루푸스
제7장 지역별·국가별 분석
세계의 루푸스 치료제 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 루푸스 치료제 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
루푸스 치료제 시장 : 경쟁 구도
루푸스 치료제 시장 : 기업 개요
Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
AstraZeneca PLC
Novartis AG
Roche Holdings Inc.
GlaxoSmithKline plc
Eli Lilly and Company
Viatris Inc.
Teva Pharmaceutical Industries Ltd.
Bausch Health Companies Inc.
Sun Pharmaceutical Industries Ltd.
Aurobindo Pharma
Dr. Reddy's Laboratories Ltd.
Hikma Pharmaceuticals PLC
Amneal Pharmaceuticals LLC
Lupin Ltd
Zydus Lifesciences Limited
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
루푸스 치료제 시장 2029 : 새로운 기회를 제공하는 국가
루푸스 치료제 시장 2029 : 새로운 기회를 제공하는 부문
루푸스 치료제 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Lupus therapeutics encompass treatments and medications specifically designed to manage and alleviate the symptoms of lupus, an autoimmune disease in which the body's immune system attacks its own tissues, causing inflammation and damage in various organs. These treatments aim to reduce inflammation, suppress the overactive immune response, and improve patients' quality of life.
The primary types of lupus therapeutics include systemic lupus erythematosus, cutaneous lupus erythematosus, drug-induced lupus erythematosus, neonatal lupus, and others. Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects various organs and tissues, characterized by inflammation and damage to these organs. Treatments for lupus include non-steroidal anti-inflammatory drugs (NSAIDs), biologics, antimalarial drugs, corticosteroids, and others. These drugs can be administered orally, subcutaneously, intravenously, and by other methods, and are used in various settings, such as hospitals and clinics, diagnostic laboratories, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The lupus therapeutics research report is one of a series of new reports from The Business Research Company that provides lupus therapeutics market statistics, including the lupus therapeutics industry's global market size, regional shares, competitors with a lupus therapeutics market share, detailed lupus therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the lupus therapeutics industry. This lupus therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The lupus therapeutics market size has grown strongly in recent years. It will grow from $2.74 billion in 2024 to $2.98 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to the increased prevalence of lupus, increased investment in healthcare infrastructure, high disposable income, high demand for effective therapies, and rising geriatric population.
The lupus therapeutics market size is expected to see strong growth in the next few years. It will grow to $4.07 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to rising drug approvals and launches, emerging markets, improvements in disease awareness and diagnosis, rising awareness initiatives, and immunosuppressive products. Major trends in the forecast period include chimeric antigen receptor T-cell (CAR-T) therapy, small molecule therapeutics for lupus, CAR-NK therapy for lupus, combined inhibition of human plasmacytoid dendritic cell activity during systemic lupus, erythematosus (SLE), urine proteomics.
The forecast of 8.2% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of biologic therapies for lupus sourced from Switzerland and Germany, thereby limiting patient access to advanced treatments and elevating rheumatology department expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The growth of the lupus therapeutics market is expected to be propelled by increasing research and development activities. These activities encompass systematic investigation and experimentation aimed at advancing knowledge, technology, or product development across various fields. They are driven by the need for innovation, technological advancements, addressing emerging challenges, improving healthcare outcomes, and fostering economic growth through scientific and technological breakthroughs. Research and development efforts contribute to advancing lupus therapeutics by discovering new treatments, enhancing existing therapies, and deepening understanding of the disease's underlying mechanisms. For instance, a March 2023 report from the Congressional Research Service highlighted that the national institutes of health received $49.183 billion in 2023 for research and development activities, marking an increase from $42.941 billion allocated in 2021. This funding underscores the growing commitment to advancing medical research, including efforts related to lupus therapeutics, thereby driving market growth.
In the lupus therapeutics market, major companies are focused on developing advanced blood tests incorporating predictive artificial intelligence to improve diagnostic accuracy and treatment efficacy. These blood tests utilize AI algorithms to analyze biomarkers in blood samples, predicting disease outcomes or treatment responses more accurately. For example, AMPEL BioSolutions LLC, a US-based precision medicine company, launched the LuGENE blood test in March 2024. This innovative test predicts lupus flares and identifies drug targets through gene expression analysis with predictive AI. It aims to revolutionize lupus management by offering personalized treatment options based on real-time abnormalities in gene expression linked to inflammation and immune dysfunction.
In April 2024, Takeda Pharmaceutical Company Limited, a Japan-based biotechnology firm, acquired Nimbus Therapeutics' TYK2 program from Nimbus Lakshmi Inc. This strategic acquisition enhances Takeda's position in the immunology market and expands its portfolio of treatments for immune-mediated diseases, including lupus. Nimbus Lakshmi Inc., based in the US, specializes in developing drugs for various conditions, including lupus and psoriasis.
Major companies operating in the lupus therapeutics market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Sanofi SA, AstraZeneca PLC, Novartis AG, Roche Holdings Inc., GlaxoSmithKline plc, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Lupin Ltd, Zydus Lifesciences Limited, Glenmark Pharmaceuticals Limited
North America was the largest region in the lupus therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lupus therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the lupus therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The lupus therapeutics market consists of revenues earned by entities by providing services such as autoantibody testing, anti-phospholipid antibody testing, and rheumatoid factor testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The lupus therapeutics market also includes sales of calcineurin inhibitors, immunosuppressants, anticoagulants, and antimalarial drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Lupus Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on lupus therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for lupus therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lupus therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Lupus Therapeutics Market Characteristics
3. Lupus Therapeutics Market Trends And Strategies
4. Lupus Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Lupus Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global Lupus Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Lupus Therapeutics Market Growth Rate Analysis
5.4. Global Lupus Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Lupus Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Lupus Therapeutics Total Addressable Market (TAM)
6. Lupus Therapeutics Market Segmentation
6.1. Global Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Systemic Lupus Erythematosus (SLE)
Cutaneous Lupus Erythematosus
Drug-Induced Lupus Erythematosus
Neonatal Lupus
6.2. Global Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Biologics
Antimalarial Drugs
Corticosteroids
Other Treatment Types
6.3. Global Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Subcutaneous
Intravenous
Other Routes Of Administration
6.4. Global Lupus Therapeutics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Laboratories
Other End Users
6.5. Global Lupus Therapeutics Market, Sub-Segmentation Of Systemic Lupus Erythematosus (SLE), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mild SLE
Moderate SLE
Severe SLE
6.6. Global Lupus Therapeutics Market, Sub-Segmentation Of Cutaneous Lupus Erythematosus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Acute Cutaneous Lupus
Subacute Cutaneous Lupus
Chronic Cutaneous Lupus (Including Discoid Lupus)
6.7. Global Lupus Therapeutics Market, Sub-Segmentation Of Drug-Induced Lupus Erythematosus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medications Known To Cause Drug-Induced Lupus
Hydralazine
Procainamide
Isoniazid
6.8. Global Lupus Therapeutics Market, Sub-Segmentation Of Neonatal Lupus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Heart-Related Neonatal Lupus
Skin-Related Neonatal Lupus
7. Lupus Therapeutics Market Regional And Country Analysis
7.1. Global Lupus Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Lupus Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Lupus Therapeutics Market
9.1. China Lupus Therapeutics Market Overview
9.2. China Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Lupus Therapeutics Market
10.1. India Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Lupus Therapeutics Market
11.1. Japan Lupus Therapeutics Market Overview
11.2. Japan Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Lupus Therapeutics Market
12.1. Australia Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Lupus Therapeutics Market
13.1. Indonesia Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Lupus Therapeutics Market
14.1. South Korea Lupus Therapeutics Market Overview
14.2. South Korea Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Lupus Therapeutics Market
15.1. Western Europe Lupus Therapeutics Market Overview
15.2. Western Europe Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Lupus Therapeutics Market
16.1. UK Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Lupus Therapeutics Market
17.1. Germany Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Lupus Therapeutics Market
18.1. France Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Lupus Therapeutics Market
19.1. Italy Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Lupus Therapeutics Market
20.1. Spain Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Lupus Therapeutics Market
21.1. Eastern Europe Lupus Therapeutics Market Overview
21.2. Eastern Europe Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Lupus Therapeutics Market
22.1. Russia Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Lupus Therapeutics Market
23.1. North America Lupus Therapeutics Market Overview
23.2. North America Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Lupus Therapeutics Market
24.1. USA Lupus Therapeutics Market Overview
24.2. USA Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Lupus Therapeutics Market
25.1. Canada Lupus Therapeutics Market Overview
25.2. Canada Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Lupus Therapeutics Market
26.1. South America Lupus Therapeutics Market Overview
26.2. South America Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Lupus Therapeutics Market
27.1. Brazil Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Lupus Therapeutics Market
28.1. Middle East Lupus Therapeutics Market Overview
28.2. Middle East Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Lupus Therapeutics Market
29.1. Africa Lupus Therapeutics Market Overview
29.2. Africa Lupus Therapeutics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Lupus Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Lupus Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Lupus Therapeutics Market Competitive Landscape And Company Profiles
